81 related articles for article (PubMed ID: 38649363)
21. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
22. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
23. METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism.
Wang Y; Chen J; Gao WQ; Yang R
Cell Death Discov; 2022 Mar; 8(1):143. PubMed ID: 35354789
[TBL] [Abstract][Full Text] [Related]
24. METTL14 promotes proliferation, migration, and invasion in endometriotic stromal cell growth by activating the ZEB1/MEK/ERK pathway.
Lv X; Li F
Gynecol Obstet Invest; 2024 Jun; ():. PubMed ID: 38934184
[TBL] [Abstract][Full Text] [Related]
25. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
26. YWHAH activates the HMGA1/PI3K/AKT/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells.
He J; Zeng F; Jin XI; Liang L; Gao M; Li W; Li G; Zhou Y
Oncol Res; 2023; 31(4):615-630. PubMed ID: 37415737
[TBL] [Abstract][Full Text] [Related]
27. RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.
Zhu K; Gao T; Wang Z; Zhang L; Tan K; Lv Z
Cell Death Discov; 2023 May; 9(1):151. PubMed ID: 37156775
[TBL] [Abstract][Full Text] [Related]
28. Role of m6A methylation in retinal diseases.
Zhu X; Zhou C; Zhao S; Zheng Z
Exp Eye Res; 2023 Jun; 231():109489. PubMed ID: 37084873
[TBL] [Abstract][Full Text] [Related]
29. YY1 transcription factor induces proliferation and aerobic glycolysis of neuroblastoma cells via LDHA regulation.
Wang Q; Fan W; Liang B; Hou B; Jiang Z; Li C
Exp Ther Med; 2023 Jan; 25(1):37. PubMed ID: 36569438
[TBL] [Abstract][Full Text] [Related]
30. ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma.
Tang W; Xu N; Zhou J; He Z; Lenahan C; Wang C; Ji H; Liu B; Zou Y; Zeng H; Guo H
Cell Death Discov; 2022 Dec; 8(1):497. PubMed ID: 36566230
[TBL] [Abstract][Full Text] [Related]
31. Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T-Cell Acute Lymphoblastic Leukemia.
Zhou Y; Ji M; Xia Y; Han X; Li M; Li W; Sun T; Zhang J; Lu F; Sun Y; Liu N; Li J; Ma D; Ye J; Ji C
Adv Sci (Weinh); 2023 Jan; 10(2):e2201724. PubMed ID: 36478193
[TBL] [Abstract][Full Text] [Related]
32. Long-term cadmium exposure impairs cognitive function by activating lnc-Gm10532/m6A/FIS1 axis-mediated mitochondrial fission and dysfunction.
Deng P; Zhang H; Wang L; Jie S; Zhao Q; Chen F; Yue Y; Wang H; Tian L; Xie J; Chen M; Luo Y; Yu Z; Pi H; Zhou Z
Sci Total Environ; 2023 Feb; 858(Pt 3):159950. PubMed ID: 36336035
[TBL] [Abstract][Full Text] [Related]
33. The regulation and potential roles of m6A modifications in early embryonic development and immune tolerance at the maternal-fetal interface.
Liu H; Zheng J; Liao A
Front Immunol; 2022; 13():988130. PubMed ID: 36225914
[TBL] [Abstract][Full Text] [Related]
34. Autophagy induction promoted by m
Hao W; Dian M; Zhou Y; Zhong Q; Pang W; Li Z; Zhao Y; Ma J; Lin X; Luo R; Li Y; Jia J; Shen H; Huang S; Dai G; Wang J; Sun Y; Xiao D
Nat Commun; 2022 Oct; 13(1):5845. PubMed ID: 36195598
[TBL] [Abstract][Full Text] [Related]
35. Role of m6A writers, erasers and readers in cancer.
Fang Z; Mei W; Qu C; Lu J; Shang L; Cao F; Li F
Exp Hematol Oncol; 2022 Aug; 11(1):45. PubMed ID: 35945641
[TBL] [Abstract][Full Text] [Related]
36. Circ_0000144 acts as a miR-1178-3p decoy to promote cell malignancy and angiogenesis by increasing YWHAH expression in papillary thyroid cancer.
Ma Y; Yang D; Guo P
J Otolaryngol Head Neck Surg; 2022 Jul; 51(1):28. PubMed ID: 35902926
[TBL] [Abstract][Full Text] [Related]
37. METTL3 Inhibits Antitumor Immunity by Targeting m
Chen H; Pan Y; Zhou Q; Liang C; Wong CC; Zhou Y; Huang D; Liu W; Zhai J; Gou H; Su H; Zhang X; Xu H; Wang Y; Kang W; Kei Wu WK; Yu J
Gastroenterology; 2022 Oct; 163(4):891-907. PubMed ID: 35700773
[TBL] [Abstract][Full Text] [Related]
38. METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer.
Wang N; Huo X; Zhang B; Chen X; Zhao S; Shi X; Xu H; Wei X
Front Oncol; 2022; 12():861807. PubMed ID: 35574388
[TBL] [Abstract][Full Text] [Related]
39. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
40. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke.
Chang H; Yang J; Wang Q; Zhao J; Zhu R
Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
